7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Navidea Biopharmaceuticals, Inc
(NYSE MKT:NAVB) 

NAVB stock logo

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept pla...

Founded: 1983
Full Time Employees: 13
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
Navidea Biopharmaceuticals Days Payable Outstanding ttm (DPO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.270.540.81.071.341.611.87Milllion
Navidea Biopharmaceuticals Days Receivable Outstanding ttm (DSO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 02.645.287.9210.5613.1915.8318.47Thousand
Navidea Biopharmaceuticals Days Inventory Outstanding ttm (DIO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 034.869.6104.4139.2174208.79243.59Thousand
Navidea Biopharmaceuticals Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -0.31-0.27-0.22-0.18-0.13-0.09-0.040
Navidea Biopharmaceuticals Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -0.33-0.28-0.23-0.19-0.14-0.09-0.050
Navidea Biopharmaceuticals Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.020.040.070.090.110.130.15
Navidea Biopharmaceuticals P/S ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 01.643.284.926.558.199.8311.47Thousand
Navidea Biopharmaceuticals (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -2.74-2.35-1.96-1.56-1.17-0.78-0.390
Navidea Biopharmaceuticals P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -4.01-3.44-2.86-2.29-1.72-1.15-0.570
No extra charts and metrics for this ticker.